|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 31/7068 | (2006.01) |
| (11) | Number of the document | 2299984 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09746975.3 |
| Date of filing the European patent application | 2009-05-14 | |
| (97) | Date of publication of the European application | 2011-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation | 2019-03-25 |
| (86) | Number | PCT/US2009/002999 |
| Date | 2009-05-14 |
| (87) | Number | WO 2009/139888 |
| Date | 2009-11-19 |
| (30) | Number | Date | Country code |
| 53609 P | 2008-05-15 | US | |
| 201145 P | 2008-12-05 | US | |
| 157875 P | 2009-03-05 | US |
| (72) |
ETTER, Jeffrey, B., US
LAI, Mei, US
BACKSTROM, Jay, Thomas, US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Peroralinės citidino analogų kompozicijos ir jų naudojimo būdai |
| ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 17 | 347.00 EUR |
| 2026-05-14 |